Odey Holdings (Switzerland)’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-500
Closed -$142K 26
2020
Q3
$142K Hold
500
1.24% 30
2020
Q2
$134K Sell
500
-100
-17% -$30.1K 1.43% 24
2020
Q1
$190K Buy
+600
New +$182K 2.32% 16
2017
Q2
Sell
-95
Closed -$26K 23
2017
Q1
$26K Sell
95
-26
-21% -$7.35K 2.23% 18
2016
Q4
$34K Buy
+121
New +$35.9K 2.2% 19

Other funds holding BIIB

Odey Holdings (Switzerland)'s BIIB Position: Q4 2020 in Review

Odey Holdings (Switzerland) sold out of Biogen (BIIB) in Q4 2020, closing a stake of 500 shares — an estimated $142K sold.

Odey Holdings (Switzerland) first reported a position in BIIB in Q4 2016 and held it in 5 quarters. The position peaked at $190K in Q1 2020. 1,061 funds tracked by Wall St. Rank hold BIIB as of Q4 2020.

  • Odey Holdings (Switzerland) reported no remaining Biogen position as of Q4 2020 after selling out during the quarter.
  • Odey Holdings (Switzerland) sold 500 Biogen shares in Q4 2020, an estimated $142K.
  • Odey Holdings (Switzerland) first reported a position in Biogen in Q4 2016 and held it in 5 quarters.
  • Odey Holdings (Switzerland)'s Biogen position peaked at $190K in Q1 2020.
  • 1,061 funds tracked by Wall St. Rank held Biogen as of Q4 2020.

Based on Odey Holdings (Switzerland)'s 13F filing for Q4 2020, filed 16 Feb 2021.